Skip to main content
Article thumbnail
Location of Repository

Botulinum toxin – From WMD to therapeutic agent and cosmetic aid

By Roger M Pinder
Topics: Editorial Foreword
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:2656310
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2007). BoNT/E prevents seizureinduced activation of caspase 3 in the rat hippocampus.
    2. (1985). Botulinum A toxin injections as a treatment for blepharospasm. Arch Ophthalmol,
    3. (1997). Botulinum toxin: the story of its development for the treatment of human disease. Perspect Biol Med,
    4. (2007). Neurologic uses of botulinum neurotoxin type A. Neuropsychiatr Dis Treat,
    5. (1973). Pharmacological weakening of the extra-ocular muscles. Invest Ophthalmol,
    6. (2007). Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache. Neuropsychiatr Dis Treat,
    7. (2006). SV2 is the protein receptor for botulinum neurotoxin A.
    8. (2006). Unlabeled uses of botulinum toxin: a review, part 1.
    9. (2006). Update on botulinum toxin. Semin Cutan Med Surg,

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.